helpline 01494 601 400


Epilepsy drug Trobalt (retigabine) to be discontinued

Packaging for Trobalt (retigabine)

The epilepsy drug Trobalt, also known as retigabine, is to be discontinued and will no longer be available after June 2017.

Researchers modify epilepsy drug to reduce side effects

Researchers have designed a more effective version of retigabine,  a drug used to treat epilepsy, offering the potential for fewer side effects.

Studies expose efficacy of two widely-prescribed epilepsy drugs

Two separate studies have analysed the benefits and side-effects of two antiepileptic drugs, rufinamide and retigabine.

Subscribe to RSS - retigabine